Page last updated: 2024-09-03

win 57273 and isepamicin

win 57273 has been researched along with isepamicin in 1 studies

Compound Research Comparison

Studies (win 57273)	Trials (win 57273)	Recent Studies (post-2010) (win 57273)	Studies (isepamicin)	Trials (isepamicin)	Recent Studies (post-2010) (isepamicin)
23	0	0	175	28	15

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett, MS; Erwin, ME; Jones, RN; Koontz, FP	1

Other Studies

1 other study(ies) available for win 57273 and isepamicin

Article	Year
CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum. Diagnostic microbiology and infectious disease, 1992, Volume: 15, Issue:2 Topics: Anti-Bacterial Agents; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium chelonae; Nontuberculous Mycobacteria; Quinolones	1992

Article

Year

CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.

Diagnostic microbiology and infectious disease, 1992, Volume: 15, Issue:2

Topics: Anti-Bacterial Agents; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium chelonae; Nontuberculous Mycobacteria; Quinolones

1992